Skip to main content

Advertisement

Table 3 Initial and highest dose of quetiapine and risperidone: A) patients with BD, B) patients without BD

From: Treatment patterns and burden of behavioral disturbances in patients with dementia in the United States: a claims database analysis

A)
Quetiapine (N = 3927) Risperidone (N = 2108)
Strength Initial Dose (n, %) Highest Dose (n, %) Strength Initial Dose (n, %) Highest Dose (n, %)
25 mg 2904 (74.0%) 2050 (52.2%) < .5 mg 978 (46.4%) 648 (30.7%)
50 mg 726 (18.5%) 1155 (29.4%) .5 mg 762 (36.2%) 842 (39.9%)
100 mg 192 (4.9%) 497 (12.7%) .6–.9 mg 0 0
150 mg 16 (.4%) 28 (.7%) 1 mg 302 (14.3%) 492 (23.3%)
200 mg 58 (1.5%) 97 (2.5%) 1.1–1.9 mg 0 0
300 mg 19 (.5%) 75 (1.9%) 2 mg 43 (2.0%) 79 (3.8%)
400 mg 12 (.3%) 25 (.6%) >  2 mg 23 (1.1%) 47 (2.2%)
B)
Quetiapine (N = 5802) Risperidone (N = 2835)
Strength Initial Dose (n, %) Highest Dose (n, %) Strength Initial Dose (n, %) Highest Dose (n, %)
25 mg 4218 (72.7%) 3509 (60.5%) < .5 mg 1209 (42.6%) 928 (32.7%)
50 mg 1041 (17.9%) 1422 (24.5%) .5 mg 1054 (37.2%) 1117(39.4%)
100 mg 314 (5.4%) 526 (9.1%) .6–.9 mg 0 (0%) 0
150 mg 34 (.6%) 56 (1.0%) 1 mg 429 (15.1%) 591 (20.9%)
200 mg 98 (1.7%) 149(2.6%) 1.1–1.9 mg 0 0
300 mg 72 (1.2%) 94(1.6%) 2 mg 83 (2.9%) 107 (3.8%)
400 mg 25 (.4%) 46 (.8%) >  2 mg 60 (2.1%) 92 (3.2%)